Look for NPC's John O'Brien at the Drug Channels Leadership Forum 2026

At this year’s Drug Channels Leadership Forum in Miami, FL, NPC President and CEO John O’Brien will participate in a crossfire debate on the 340B Drug Pricing Program alongside Maureen Testoni of 340B Health and Luke Greenwalt of IQVIA. 

Crossfire: The 340B Drug Pricing Program

Tuesday, March 17, 2026 | 3:30 PM - 4:15 PM

Moderator:

• Luke Greenwalt, MBA, VP and Lead, IQVIA Market Access Center of Excellence, IQVIA

Panelists:

• John M. O'Brien, PharmD, MPH, President and Chief Executive Officer, National Pharmaceutical Council
• Maureen Testoni, JD, President and Chief Executive Officer, 340B Health